Aliyah Sohani, MD
Aliyah Sohani, MD
Associate Chief for Clinical Affairs, Department of Pathology
Director of Surgical Pathology, Massachusetts General Hospital
Professor of Pathology, Harvard Medical School
Departments, Centers, & Programs:
Mass General Pathology
55 Fruit St.
Boston, MA 02114
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital*****
- Fellowship, Massachusetts General Hospital*****
American Board Certifications
- Anatomic Pathology & Clinical Pathology, American Board of Pathology
- Hematology, American Board of Pathology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Sohani's academic activities have focused on the classification and characterization of various lymphoma subtypes, including rare and difficult-to-study lymphoid malignancies. Her research has identified morphologic, immunologic, and genetic features of these tumors that further the understanding of their pathogenesis, define accurate diagnostic criteria, and serve to predict tumor behavior and response to therapy. These efforts have led to the contribution of new knowledge and several key innovations to the field of lymphoma diagnosis and classification, including the first description of unusual, non-neoplastic T-cell populations in nodular lymphocyte predominant Hodgkin lymphoma; improved methods of screening for and diagnosing aggressive high-grade B-cell lymphomas with MYC and BCL2 rearrangements (double-hit lymphoma); improved diagnostic guidelines related to recognition by pathologists of rare cases of extranodal NK/T-cell lymphoma with deceptively bland cytomorphology; immunophenotypic and genetic evidence supporting the distinct pathogenesis of EBV-negative vs. EBV+ monomorphic post-transplant lymphoproliferative disorder; and development of an immunohistochemistry-based biologic risk score in primary mediastinal large B-cell lymphoma.